Applied dna submits validation package to new york state department of health for approval of pharmacogenomic (pgx) assay

Stony brook, n.y.--(business wire)---- $apdn #nysdoh--applied dna sciences, inc. (nasdaq: apdn) (the “company”), a leader in pcr-based dna technologies, today announced that its wholly-owned clinical laboratory subsidiary, applied dna clinical labs, llc (adcl), has submitted a validation package to the new york state department of health (nysdoh) in support of approval for a pharmacogenomics (pgx) assay as a nysdoh laboratory-developed test (ldt).
APDN Ratings Summary
APDN Quant Ranking